Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
InnoCan Pharma: Jetzt in die Doppel-Chance investieren?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema CLEARSIDE

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
DiClearside Biomedical, Inc.: Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®2
16.05.Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying3
10.05.Earnings call: Clearside Biomedical updates on Q1 2024 and future plans1
10.05.Clearside Biomedical, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
10.05.Clearside Biomedical, Inc. - 10-Q, Quarterly Report1
09.05.Clearside Biomedical GAAP EPS of -$0.17 misses by $0.03, revenue of $0.23M misses by $0.45M1
09.05.Clearside Biomedical, Inc. - 8-K, Current Report1
08.05.Clearside Biomedical Q1 2024 Earnings Preview1
08.05.Clearside Biomedical, Inc.: Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference1
30.04.Clearside Biomedical, Inc.: Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 20241
16.04.Clearside Biomedical, Inc. - 8-K, Current Report2
16.04.Clearside Biomedical, Inc.: Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors1
02.04.Clearside Biomedical, Inc.: Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference1
18.03.Clearside Biomedical appoints Chong as CMO2
18.03.Clearside Biomedical, Inc.: Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer549ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...
► Artikel lesen
13.03.Earnings call: Clearside Biomedical reports on clinical trials and collaborations5
12.03.Clearside Biomedical Inc reports results for the quarter ended in December - Earnings Summary3
12.03.Clearside Biomedical, Inc. - 10-K, Annual Report1
12.03.Clearside Biomedical, Inc. - 8-K, Current Report2
12.03.Clearside Biomedical, Inc.: Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update37- Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 - - Partner Programs Continue to Report Positive Clinical Data Utilizing SCS Microinjector® - - Strengthened...
► Artikel lesen
Seite:  Weiter >>